Global Alpha 1 Antitrypsin Deficiency Treatment Market Research Report 2019

Table of Contents

Executive Summary

1 Alpha 1 Antitrypsin Deficiency Treatment Market Overview

• 1.1 Product Overview and Scope of Alpha 1 Antitrypsin Deficiency Treatment
• 1.2 Alpha 1 Antitrypsin Deficiency Treatment Segment by Type
  • 1.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Augmentation Therapy
  • 1.2.3 Bronchodilators
  • 1.2.4 Corticosteroids
  • 1.2.5 Oxygen Therapy
• 1.3 Alpha 1 Antitrypsin Deficiency Treatment Segment by Application
  • 1.3.1 Alpha 1 Antitrypsin Deficiency Treatment Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Specialty Clinics
  • 1.3.4 Pharmacies
• 1.4 Global Alpha 1 Antitrypsin Deficiency Treatment Market by Region
  • 1.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size
  • 1.5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (2014-2025)
  • 1.5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Production (2014-2025)

2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Competition by Manufacturers

• 2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Alpha 1 Antitrypsin Deficiency Treatment Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Production Sites, Area Served, Product Types
• 2.5 Alpha 1 Antitrypsin Deficiency Treatment Market Competitive Situation and Trends
  • 2.5.1 Alpha 1 Antitrypsin Deficiency Treatment Market Concentration Rate
  • 2.5.2 Alpha 1 Antitrypsin Deficiency Treatment Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Regions

• 3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Regions
• 3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions (2014-2019)
• 3.3 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Alpha 1 Antitrypsin Deficiency Treatment Production
  • 3.4.1 North America Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2014-2019)
  • 3.4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Alpha 1 Antitrypsin Deficiency Treatment Production
  • 3.5.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2014-2019)
  • 3.5.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Alpha 1 Antitrypsin Deficiency Treatment Production (2014-2019)
  • 3.6.1 China Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2014-2019)
  • 3.6.2 China Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Alpha 1 Antitrypsin Deficiency Treatment Production (2014-2019)
  • 3.7.1 Japan Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2014-2019)
  • 3.7.2 Japan Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption by Regions

• 4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption by Regions
• 4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Consumption (2014-2019)
• 4.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption (2014-2019)
• 4.4 China Alpha 1 Antitrypsin Deficiency Treatment Consumption (2014-2019)
• 4.5 Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption (2014-2019)

5 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price Trend by Type

• 5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Type (2014-2019)
• 5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Type (2014-2019)
• 5.3 Global Alpha 1 Antitrypsin Deficiency Treatment Price by Type (2014-2019)
• 5.4 Global Alpha 1 Antitrypsin Deficiency Treatment Production Growth by Type (2014-2019)

6 Global Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Applications

• 6.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Application (2014-2019)
• 6.2 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Alpha 1 Antitrypsin Deficiency Treatment Business

• 7.1 Pfizer
  • 7.1.1 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.1.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Baxter
  • 7.2.1 Baxter Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.2.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 AstraZeneca
  • 7.3.1 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.3.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Grifols
  • 7.4.1 Grifols Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.4.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Teva Pharmaceutical Industries
  • 7.5.1 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.5.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Boehringer Ingelheim
  • 7.6.1 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.6.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.6.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Kamada Ltd
  • 7.7.1 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.7.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.7.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 GlaxoSmithKline
  • 7.8.1 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.8.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.8.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 CSL Behring
  • 7.9.1 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.9.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Shire
  • 7.10.1 Shire Alpha 1 Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 7.10.2 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction, Application and Specification
  • 7.10.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 LFB Biomedicaments
• 7.12 Abeona Therapeutics
• 7.13 Biogen
• 7.14 Applied Genetic Technologies
• 7.15 Baxalta
• 7.16 Arrowhead Research Corporation
• 7.17 ProBioGen
• 7.18 Chiesi Pharmaceuticals
• 7.19 Curaxys
• 7.20 ProMetic Life Sciences

8 Alpha 1 Antitrypsin Deficiency Treatment Manufacturing Cost Analysis

• 8.1 Alpha 1 Antitrypsin Deficiency Treatment Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Alpha 1 Antitrypsin Deficiency Treatment
• 8.4 Alpha 1 Antitrypsin Deficiency Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Alpha 1 Antitrypsin Deficiency Treatment Distributors List
• 9.3 Alpha 1 Antitrypsin Deficiency Treatment Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Alpha 1 Antitrypsin Deficiency Treatment Market Forecast

• 11.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue Forecast
  • 11.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Alpha 1 Antitrypsin Deficiency Treatment Price and Trend Forecast (2019-2025)
• 11.2 Global Alpha 1 Antitrypsin Deficiency Treatment Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue Forecast (2019-2025)
• 11.3 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2019-2025)
  • 11.3.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2019-2025)
  • 11.3.3 China Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2019-2025)
  • 11.3.4 Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast (2019-2025)
• 11.4 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List